On Monday, officials with Meridian Bioscience Inc., a provider of diagnostic testing and life science raw materials, announced their pending $1.53 billion merger with two South Korean-based firms will close Jan. 31.
On Monday, officials with Meridian Bioscience Inc., a provider of diagnostic testing and life science raw materials, announced their pending $1.53 billion merger with two South Korean-based firms will close Jan. 31.
